Articles tagged with Biotech from PMD http://www.pmdcentral.com/biotech/topic/1132/ Articles tagged with Biotech from PMD ImmunoCellular Therapeutics Issues Letter to Shareholders Update on Company's Accomplishments http://www.pmdcentral.com/immunocellular-therapeutics-issues-letter-to-shareholders/article/178193/ Fri, 03 Sep 2010 09:22:54 GMT Luminex Announces Commercial Launch of New Cystic Fibrosis Test New Test Detects up to 60 Genetic Mutations http://www.pmdcentral.com/luminex-announces-commercial-launch-of-new-cystic-fibrosis-test/article/177665/ Fri, 27 Aug 2010 10:23:13 GMT BioMarin Acquires ZyStor Therapeutics, Inc. ZyStor's lead product candidate is ZC-701 http://www.pmdcentral.com/biomarin-acquires-zystor-therapeutics-inc/article/177067/ Wed, 18 Aug 2010 09:14:51 GMT Signum Biosciences Names Braham Shroot as Chief Executive Officer Experienced pharmaceutical executive leads innovative biotech company http://www.pmdcentral.com/signum-biosciences-names-braham-shroot-as-chief-executive-officer/article/176397/ Thu, 05 Aug 2010 10:04:37 GMT Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc. Diagnostic technologies will strengthen and complement Radient's core business http://www.pmdcentral.com/radient-pharmaceuticals-enters-into-a-letter-of-intent-to-acquire-provista-diagnostics-inc/article/174473/ Tue, 13 Jul 2010 10:30:54 GMT Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer T-DM1 is the First Antibody-Drug Conjugate in Genentech's Pipeline to Be Submitted to the FDA http://www.pmdcentral.com/genentech-submits-application-to-fda-for-trastuzumab-dm1-in-previously-treated-advanced-her2-positive-breast-cancer/article/174062/ Wed, 07 Jul 2010 10:03:01 GMT Celgene to Acquire Abraxis BioScience Inc. Celgene to pay $2.9 billion in cash and stock http://www.pmdcentral.com/celgene-to-acquire-abraxis-bioscience-inc/article/173606/ Wed, 30 Jun 2010 10:39:17 GMT Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer Company Continues Its Focus on Maximizing the Value of Its Two Marketed Anticancer Drugs http://www.pmdcentral.com/spectrum-pharmaceuticals-appoints-james-e-shields-as-chief-commercial-officer/article/173054/ Wed, 23 Jun 2010 09:44:21 GMT FDA Approves Lucentis® (Ranibizumab Injection) for the Treatment of Macular Edema Following Retinal Vein Occlusion New indication approved after a six-month Priority Review http://www.pmdcentral.com/fda-approves-lucentis-ranibizumab-injection-for-the-treatment-of-macular-edema-following-retinal-vein-occlusion/article/173053/ Wed, 23 Jun 2010 09:39:02 GMT Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer Expanding Senior Management Team Supports Next-Generation Platform for Antibody Drug Discovery http://www.pmdcentral.com/ablexis-appoints-r-scott-greer-chairman-of-the-board-and-richard-hoffman-chief-business-officer/article/172980/ Tue, 22 Jun 2010 09:18:02 GMT